Physician profile
Aida Girma
NPI 1396123147
$1,249.55
in general payments reported to CMS, 2019-2025
17 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $284 · 2024: $470 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $301.07 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Organon LLC | $111.28 | 2022-2025 | Nexplanon |
| Pfizer INC. | $108.57 | 2023-2025 | |
| Lilly USA, LLC | $105.86 | 2025 | Zepbound, Mounjaro |
| Mayne Pharma Commercial LLC | $105.04 | 2023-2024 | |
| Dynavax Technologies Corporation | $99.46 | 2023-2025 | Heplisav-B |
| Astellas Pharma US INC | $89.23 | 2022-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $66.70 | 2023 | |
| Daiichi Sankyo INC. | $63.67 | 2023-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $49.38 | 2022-2023 | |
| Amgen INC. | $36.12 | 2025 | Repatha |
| Abbvie INC. | $24.37 | 2022 | |
| Therapeuticsmd, INC. | $21.16 | 2022 | |
| Exact Sciences Corporation | $19.25 | 2025 | Cologuard Collection Kit |
| Seqirus USA INC | $19.04 | 2025 | Fluad, Flucelvax |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $14.99 | 2022 | |
| Glaxosmithkline, LLC. | $14.36 | 2024 | Shingrix, Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aida Girma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.